Similar articles

• Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer.

  Glasgow AH, Nimberg RB, Menzoian JO, Saporoschetz I, Cooperband SR, Schmid K, Mannick JA. Glasgow AH, et al. N Engl J Med. 1974 Dec 12;291(24):1263-7. doi: 10.1056/NEJM197412122912401. N Engl J Med. 1974. PMID: 4610386 No abstract available.
• Isolation of an immunosuppressive peptide fraction from the serum of cancer patients.

  Nimberg RB, Glasgow AH, Menzoian JO, Constantian MB, Cooperband SR, Mannick JA, Schmid K. Nimberg RB, et al. Cancer Res. 1975 Jun;35(6):1489-94. Cancer Res. 1975. PMID: 1131820
• Allogeneic suppression: inhibition of antibody plaque forming cells in vitro by non-sensitized lymphoid cells.

  Friedman H. Friedman H. Transplant Proc. 1969 Mar;1(1):574-6. Transplant Proc. 1969. PMID: 4944273 No abstract available.
• Immunosuppressive effects of phytohemagglutinin.

  Elion GB, Blancuzzi V, Zahner E. Elion GB, et al. Transplant Proc. 1969 Mar;1(1):622-3. Transplant Proc. 1969. PMID: 4944280 No abstract available.
• Specific heterologous enhancement of immune responses. V. Isolation of a soluble enhancing factor from supernatants of specifically stimulated and allogeneically induced lymphoid cells.

  Rubin AS, MacDonald AB, Coons AH. Rubin AS, et al. J Immunol. 1973 Nov;111(5):1314-25. J Immunol. 1973. PMID: 4583072 No abstract available.